South San Francisco, CA
Vir Biotechnology is a clinical-stage immunology company that engineers antibodies into medicines, with a lead focus on infectious disease (chronic hepatitis delta is its most advanced program, alongside past COVID-19 and Ebola work) and a growing oncology pipeline built on its PRO-XTEN masking platform and a next-generation antibody/T-cell engager platform. CEO Marianne De Backer frames the pitch as speed — 'we engineer antibodies into powerful, impactful medicines, and deliver them to patients who are waiting - fast.' Culture-wise it leans into a mission-driven identity (it calls its principles 'Virtues' and its staff '#Virites') and publishes U.S. salary ranges internally for pay transparency. Honest caveat: like much of clinical-stage biotech, it is pipeline-dependent and has weathered strategic shifts as its COVID-era antibody business wound down.
see the full file on Vir Biotechnology, Inc.| Unlimited PTO | yes |
|---|---|
| Free on-site parking | yes |
| Food | lunch |
| Commuter benefit | yes |
| Parking or transit | yes |
Every claim above is sourced and dated. See sources on the full page.
Work at Vir Biotechnology, Inc. and something here is wrong or out of date? Tell us at hello@perks.global and we will check it.